The feds rejected a whistleblower's complaints that the FDA erred when it approved imaging devices for breast and colon cancer screening. The complaint appears to stem from a group of FDA employees whose computers were monitored by the agency after they allegedly leaked sensitive regulatory documents to the media. Congress criticized the agency for monitoring their computers but decided not to follow up on their safety complaints. Now, the group seems to have been rejected by the government again. (The name of the complainant wasn't officially revealed.) A successful complaint could have netted the (failed) whistleblower lots of money, as evidenced by the large sums the government has been paying to those who alert the feds about Medicare fraud. More